By admin
According to the Tufts Center for the Study of Drug Development, the average clinical trial can take 7–10 years from discovery to approval, and delays…
By admin
Clinical data review has always been one of those parts of a trial that takes more time than anyone expects. An industry report by NIH…
By admin
Let’s take a minute to think about what it really takes to bring a new medicine to patients- it’s a massive, critical effort, but too…
By admin
How AI evolved from pattern recognition to autonomous reasoning, and why pharmaceutical leaders need to understand the difference The $2.23 Billion Question Developing a single…
By admin
If you read Part 1 of this series, you’ve already seen how Interactive Review Listings (IRLs) simplify and speed up the core data review process….
By admin
In the high-stakes environment of clinical development, the burden of documentation has reached a tipping point. Medical writers and clinical teams are increasingly sidelined by…
By admin
The period immediately following Data Base Lock (DBL) is often the most stressful window in a clinical trial. While the “hard work” of data collection…
By admin
Clinical trials generate enormous amounts of data. For decades, the industry has relied on a familiar approach to keep that data clean through rules, edit…
By admin
Ask any clinical operations leader where study startup time disappears, and the answer rarely points to a single dramatic failure. More often, the culprit is…
By admin
The drug development industry is moving faster than ever, and timelines are continuing to shorten across parts of the process. AI is increasingly being applied…
By admin
Modern clinical trials generate data continuously, from the moment the first patient is enrolled. Yet most data management teams are still built around workflows designed…
By admin
Clinical development has always been expensive. But in 2026, the economics are drawing sharper attention. Developing a single new molecular entity now routinely requires between…
